Autolus Therapeutics (AUTL) Gross Profit (2024 - 2025)
Autolus Therapeutics posted quarterly Gross Profit of -$1.0 million for Q4 2025, up 90.83% year-on-year from -$545498.4 in Q4 2024, and up 86.02% on a QoQ basis from -$7.4 million in Q3 2025.
Autolus Therapeutics (AUTL) has 2 years of Gross Profit data on file, last reported at -$1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 90.83% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2025 stood at -$21.0 million (down 1567.81% YoY), and the FY2025 full-year result was -$21.0 million, down 1555.96% from the prior year.
- Gross Profit for Q4 2025 stood at -$1.0 million, up from -$7.4 million in the prior quarter.
- Across five years, Gross Profit topped out at $10.1 million in Q1 2024 and bottomed at -$11.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.04 Mn |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Jun 30, 2025 | -3.52 Mn |
| Jun 30, 2025 | -3.52 Mn |
| Mar 31, 2025 | -8.97 Mn |
| Mar 31, 2025 | -8.97 Mn |
| Dec 31, 2024 | -11.36 Mn |
| Dec 31, 2024 | -11.36 Mn |
| Mar 31, 2024 | 10.10 Mn |
| Mar 31, 2024 | 10.10 Mn |